Education
About Us
Working with TipRanks
Follow Us
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291)
:2291
RESEARCH TOOLSreports
Total Valuation
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has a market cap or net worth of HK$9.02B. The enterprise value is HK$4.73B.
Market CapHK$9.02B
Enterprise ValueHK$4.73B
Share Statistics
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has 346,750,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding346,750,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 12.29%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)12.29%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.50M
Profits Per Employee782.04K
Employee Count314
Asset Turnover0.23
Inventory Turnover0.55
Valuation Ratios
The current PE Ratio of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H is 33.9. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s PEG ratio is ―.
PE Ratio33.9
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.84
Price to FCF0.00
Price to Operating Cash Flow29.84
PEG Ratio―
Income Statement
In the last 12 months, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H had revenue of 471.64M and earned 245.56M in profits. Earnings per share was 0.71.
Revenue471.64M
Gross Profit424.03M
Operating Income286.14M
Pretax Income286.09M
Net Income245.56M
EBITDA288.10M
Earnings Per Share (EPS)0.71
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures -31.00M, giving a free cash flow of 137.05M billion.
Operating Cash Flow0.00
Free Cash Flow137.05M
Free Cash Flow per Share0.40
Dividends & Yields
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pays an annual dividend of HK$0.674, resulting in a dividend yield of 2.55%
Dividend Per ShareHK$0.674
Dividend Yield2.55%
Payout Ratio87.72%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change65.02%
50-Day Moving Average23.30
200-Day Moving Average19.11
Relative Strength Index (RSI)51.06
Average Volume (3m)789.85K
Important Dates
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H upcoming earnings date is Mar 27, 2026, TBA (Confirmed).
Last Earnings DateAug 22, 2025
Next Earnings DateMar 27, 2026
Ex-Dividend DateMay 26, 2025
Financial Position
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H as a current ratio of 16.79, with Debt / Equity ratio of 0.08%
Current Ratio16.79
Quick Ratio15.76
Debt to Market Cap0.00
Net Debt to EBITDA-3.90
Interest Coverage Ratio1.74K
Taxes
In the past 12 months, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has paid 40.53M in taxes.
Income Tax40.53M
Effective Tax Rate0.14
Enterprise Valuation
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H EV to EBITDA ratio is 15.79, with an EV/FCF ratio of 33.19.
EV to Sales9.65
EV to EBITDA15.79
EV to Free Cash Flow33.19
EV to Operating Cash Flow20.45
Balance Sheet
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has HK$1.13B in cash and marketable securities with HK$1.51M in debt, giving a net cash position of -HK$1.12B billion.
Cash & Marketable SecuritiesHK$1.13B
Total DebtHK$1.51M
Net Cash-HK$1.12B
Net Cash Per Share-HK$3.24
Tangible Book Value Per ShareHK$4.90
Margins
Gross margin is 89.90%, with operating margin of 60.67%, and net profit margin of 52.06%.
Gross Margin89.90%
Operating Margin60.67%
Pretax Margin60.66%
Net Profit Margin52.06%
EBITDA Margin61.08%
EBIT Margin60.69%
Analyst Forecast
The average price target for LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―